FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2160474387> ?p ?o ?g. }

• W2160474387 endingPage "E264" @default.
• W2160474387 startingPage "E253" @default.
• W2160474387 abstract "A possible association between glucagon-like peptide-1 (GLP-1) analogs and incidences of pancreatitis has been suggested based on clinical studies. In male and female diabetic Zucker diabetic fatty (ZDF) rats, we investigated the effects of continuous administration of liraglutide and exenatide on biochemical [lipase, pancreatic amylase (P-amylase)] and histopathological markers of pancreatitis. Male and female ZDF rats were dosed for 13 wk with liraglutide (0.4 or 1.0 mg·kg −1 ·day −1 sc once daily) or exenatide (0.25 mg·kg −1 ·day −1 sc, Alzet osmotic minipumps). P-amylase and lipase plasma activity were measured, and an extended histopathological and stereological (specific cell mass and proliferation rate) evaluation of the exocrine and the endocrine pancreas was performed. Expectedly, liraglutide and exenatide lowered blood glucose and Hb A 1c in male and female ZDF rats, whereas β-cell mass and proliferation rate were increased with greatly improved blood glucose control. Whereas neither analog affected lipase activity, small increases in P-amylase activity were observed in animals treated with liraglutide and exenatide. However, concurrent or permanent increases in lipase and P-amylase activity were never observed. Triglycerides were lowered by both GLP-1 analogs. The qualitative histopathological findings did not reveal adverse effects of liraglutide. The findings were mainly minimal in severity and focal in distribution. Similarly, the quantitative stereological analyses revealed no effects of liraglutide or exenatide on overall pancreas weight or exocrine and duct cell mass or proliferation. The present study demonstrates that, in overtly diabetic male and female ZDF rats, prolonged exposure to GLP-1 receptor agonists does not affect biochemical or histopathological markers of pancreatitis, and whereas both exenatide and liraglutide increase β-cell mass, they have no effect on the exocrine pancreas. However, clinical outcome studies and studies using primate tissues and/or studies in nonhuman primates are needed to further assess human risk." @default.
• W2160474387 created "2016-06-24" @default.
• W2160474387 creator A5030736840 @default.
• W2160474387 creator A5041608440 @default.
• W2160474387 creator A5051655702 @default.
• W2160474387 creator A5075602116 @default.
• W2160474387 creator A5088582143 @default.
• W2160474387 creator A5088597413 @default.
• W2160474387 creator A5088627727 @default.
• W2160474387 date "2012-07-15" @default.
• W2160474387 modified "2023-10-02" @default.
• W2160474387 title "The effects of 13 wk of liraglutide treatment on endocrine and exocrine pancreas in male and female ZDF rats: a quantitative and qualitative analysis revealing no evidence of drug-induced pancreatitis" @default.
• W2160474387 cites W1507814807 @default.
• W2160474387 cites W1558182564 @default.
• W2160474387 cites W1805517524 @default.
• W2160474387 cites W1970638723 @default.
• W2160474387 cites W1971221018 @default.
• W2160474387 cites W1988031087 @default.
• W2160474387 cites W1998922126 @default.
• W2160474387 cites W2009969219 @default.
• W2160474387 cites W2010395737 @default.
• W2160474387 cites W2024440860 @default.
• W2160474387 cites W2029214914 @default.
• W2160474387 cites W2032322539 @default.
• W2160474387 cites W2033088588 @default.
• W2160474387 cites W2044903738 @default.
• W2160474387 cites W2047316432 @default.
• W2160474387 cites W2049363653 @default.
• W2160474387 cites W2055211166 @default.
• W2160474387 cites W2062128447 @default.
• W2160474387 cites W2075013210 @default.
• W2160474387 cites W2092361523 @default.
• W2160474387 cites W2094195067 @default.
• W2160474387 cites W2098008729 @default.
• W2160474387 cites W2102052385 @default.
• W2160474387 cites W2109327370 @default.
• W2160474387 cites W2112981414 @default.
• W2160474387 cites W2115357902 @default.
• W2160474387 cites W2118889627 @default.
• W2160474387 cites W2121134199 @default.
• W2160474387 cites W2122696108 @default.
• W2160474387 cites W2124831863 @default.
• W2160474387 cites W2127409471 @default.
• W2160474387 cites W2142395926 @default.
• W2160474387 cites W2153323738 @default.
• W2160474387 cites W2164535707 @default.
• W2160474387 cites W2170606300 @default.
• W2160474387 cites W4210998956 @default.
• W2160474387 cites W4245077161 @default.
• W2160474387 doi "https://doi.org/10.1152/ajpendo.00182.2012" @default.
• W2160474387 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22589391" @default.
• W2160474387 hasPublicationYear "2012" @default.
• W2160474387 type Work @default.
• W2160474387 sameAs 2160474387 @default.
• W2160474387 citedByCount "78" @default.
• W2160474387 countsByYear W21604743872012 @default.
• W2160474387 countsByYear W21604743872013 @default.
• W2160474387 countsByYear W21604743872014 @default.
• W2160474387 countsByYear W21604743872015 @default.
• W2160474387 countsByYear W21604743872016 @default.
• W2160474387 countsByYear W21604743872017 @default.
• W2160474387 countsByYear W21604743872018 @default.
• W2160474387 countsByYear W21604743872019 @default.
• W2160474387 countsByYear W21604743872020 @default.
• W2160474387 countsByYear W21604743872021 @default.
• W2160474387 countsByYear W21604743872022 @default.
• W2160474387 countsByYear W21604743872023 @default.
• W2160474387 crossrefType "journal-article" @default.
• W2160474387 hasAuthorship W2160474387A5030736840 @default.
• W2160474387 hasAuthorship W2160474387A5041608440 @default.
• W2160474387 hasAuthorship W2160474387A5051655702 @default.
• W2160474387 hasAuthorship W2160474387A5075602116 @default.
• W2160474387 hasAuthorship W2160474387A5088582143 @default.
• W2160474387 hasAuthorship W2160474387A5088597413 @default.
• W2160474387 hasAuthorship W2160474387A5088627727 @default.
• W2160474387 hasConcept C126322002 @default.
• W2160474387 hasConcept C134018914 @default.
• W2160474387 hasConcept C170835558 @default.
• W2160474387 hasConcept C181199279 @default.
• W2160474387 hasConcept C185592680 @default.
• W2160474387 hasConcept C2777180221 @default.
• W2160474387 hasConcept C2778764654 @default.
• W2160474387 hasConcept C2778881409 @default.
• W2160474387 hasConcept C2780533449 @default.
• W2160474387 hasConcept C2781308992 @default.
• W2160474387 hasConcept C55493867 @default.
• W2160474387 hasConcept C555293320 @default.
• W2160474387 hasConcept C71924100 @default.
• W2160474387 hasConceptScore W2160474387C126322002 @default.
• W2160474387 hasConceptScore W2160474387C134018914 @default.
• W2160474387 hasConceptScore W2160474387C170835558 @default.
• W2160474387 hasConceptScore W2160474387C181199279 @default.
• W2160474387 hasConceptScore W2160474387C185592680 @default.
• W2160474387 hasConceptScore W2160474387C2777180221 @default.
• W2160474387 hasConceptScore W2160474387C2778764654 @default.
• W2160474387 hasConceptScore W2160474387C2778881409 @default.
• W2160474387 hasConceptScore W2160474387C2780533449 @default.
• W2160474387 hasConceptScore W2160474387C2781308992 @default.

• next